Bis-(1H-imidazol-2-YL)-methanone → HCID 54684212, compound
Reaction equation
[CH2:1]([N:8]([CH3:30])[CH2:9][CH2:10][C:11]1[N:16]=[C:15]([C:17]([NH:19][CH2:20][C:21]2[CH:26]=[CH:25][C:24]([F:27])=[CH:23][CH:22]=2)=[O:18])[C:14]([OH:28])=[C:13]([OH:29])[N:12]=1)C1C=CC=CC=1.C(C1NC=CN=1)(C1NC=CN=1)=[O:32].CC(C)([O-])C.[K+]>[Pd].O1CCOCC1>[F:27][C:24]1[CH:23]=[CH:22][C:21]([CH2:20][NH:19][C:17]([C:15]2[N:16]=[C:11]3[CH2:10][CH2:9][N:8]([CH3:1])[C:30](=[O:32])[N:12]3[C:13](=[O:29])[C:14]=2[OH:28])=[O:18])=[CH:26][CH:25]=1Participants
6
Procedure
A methanolic solution of 2-{2-[benzyl(methyl)amino]ethyl}-N-(4-fluorobenzyl)-5,6-dihydroxypyrimidine-4-carboxamide prepared as described in Step 4 was stirred under H2 atmosphere in the presence of catalytic 10% Pd/C for 2 hours. The reaction mixture was filtered through celite to remove the catalyst then concentrated under reduced pressure. MS (ES) C17H17FN4O3 requires 320. Found: 321 (M+H+). The crude organic product was treated with carbonyl diimidazole (1.5 equivalents) and potassium tert-butoxide in refluxing dioxane for 1 hour. Title compound was purified by RP HPLC (C18, 5 μM, H2O/MeCN with 1% of TFA as eluant). Lyophilization of appropriate fractions gave title compound as a white solid.
Workup
- filtrationThe reaction mixture was filtered through celite
- customto remove the catalyst
- concentrationthen concentrated under reduced pressure
- customTitle compound was purified by RP HPLC (C18, 5 μM, H2O/MeCN with 1% of TFA as eluant)
Sources & evidence
- ORD record
- ord-f2a1850d2df0446ab2fb35f2c53d3cb4
- Source dataset
- uspto-grants-2011_07
- Patent number
- US07981879B2
Reaction notes
Loading…